US Executive Compensation Proxy SEC Filings — August 17, 2026

17-08-2026

Interactive Strength Inc. (TRNR) filed a definitive proxy statement (DEF 14A) on August 17, 2026, for a Special Meeting of Stockholders to be held on August 28, 2026. The meeting seeks stockholder approval for several proposals, including the issuance of 20% or more of outstanding common stock upon conversion of existing preferred stock and new Series F Preferred Stock issued to STEPR, Inc. shareholders, as well as an amendment to the 2023 Stock Incentive Plan to add 5,000,000 shares and an automatic share increase provision. The company also proposes granting the Board authority to effect a reverse stock split at a ratio between 1-for-4 and 1-for-100, with an aggregate limit of 1-for-100, to be completed within one year of the record date.

• · The Special Meeting will be held on August 28, 2026 at 10:00 a.m. Central Time at 1005 Congress Ave, Suite 925, Austin, Texas 78701.
• · Record date for voting is August 13, 2026.
• · The Board recommends a vote 'FOR' all six proposals.
• · Proposals include approval of issuance of 20% or more of outstanding shares upon conversion of Existing Preferred Stock, Series F Preferred Stock (for STEPR acquisition), convertible notes, and warrants.
• · The Reverse Stock Split proposal allows a ratio range from 1-for-4 up to 1-for-100, with an aggregate limit of 1-for-100, to be completed within one year of the record date.
• · Stockholders may vote by Internet, telephone, or mail; beneficial owners must obtain a legal proxy from their broker.

17-08-2026

FedEx Corporation filed its definitive proxy statement (DEF 14A) for the 2026 annual meeting of stockholders, to be held virtually on September 28, 2026. The filing highlights a strong fiscal 2026 performance, with shares trading at all-time highs, and the successful spin-off of FedEx Freight as an independent public company. However, the company also notes the passing of founder Frederick W. Smith, board departures, and a volatile global environment marked by geopolitical conflict and trade friction.

• · The annual meeting will be a virtual-only meeting at www.virtualshareholdermeeting.com/FDX2026.
• · Stockholders of record as of August 3, 2026, are entitled to vote.
• · The Board recommends voting FOR all 11 director nominees, FOR the advisory vote on executive compensation, FOR ratification of Ernst & Young as auditor, and AGAINST all three stockholder proposals.
• · The spin-off of FedEx Freight was completed on June 1, 2026, with stockholders receiving one share of FedEx Freight common stock for every two shares of FedEx common stock.
• · Frederick W. Smith was named to Forbes' America's 250 Greatest Historic Innovators List.
• · The proxy statement includes a CEO pay ratio disclosure and pay versus performance table.

17-08-2026

HeartCore Enterprises filed its DEF 14A proxy statement for its 2026 Annual Meeting, proposing the election of five director nominees (Sumitaka Yamamoto, Ferdinand Groenewald, Kimio Hosaka, Yoonji Lee, Koji Sato) and ratification of MaloneBailey as independent auditor for FY 2026. The Board currently has two vacancies and expects to reduce its size from seven to five directors. The combined Chairman/CEO role is held by Mr. Yamamoto, with no separation of those positions.

• · Proposal 1 (election of directors): requires affirmative majority of votes cast at the meeting; 'withhold' and broker non-votes have no effect.
• · Proposal 2 (ratification of MaloneBailey): requires affirmative majority of votes present and entitled to vote; abstentions count as votes against.
• · Broker non-votes are permitted for Proposal 2 (routine) but not for Proposal 1 (non-routine).
• · Quorum is 757,665 shares (majority of outstanding voting power).
• · The Board expects to reduce its size from the current seven (with two vacancies) to five directors in the near future.
• · Board leadership structure combines Chairman and CEO roles in Sumitaka Yamamoto; no lead independent director is appointed at this time.

17-08-2026

Coda Octopus Group, Inc. filed its definitive proxy statement (DEF 14A) on August 17, 2026, for the 2026 Annual Meeting of Stockholders. The Board unanimously recommends the election of seven director nominees, including CEO Annmarie Gayle (Chairman) and independent directors with extensive financial, defense, and AI expertise. The filing highlights a combined CEO/Chairman leadership structure and notes that all directors except Ms. Gayle and Mr. Cunningham are independent under NASDAQ standards, while Stephen Hemedes is independent for general Board service but not for Audit Committee purposes.

• · The Board has determined that all directors are independent under NASDAQ standards except CEO Annmarie Gayle and Blair Cunningham.
• · Stephen Hemedes is independent for general Board service but not for Audit Committee purposes.
• · The Audit Committee consists of Michael Hamilton (Chairman), Robert Harcourt, and Gwenael Rouy-Poirier, and met five times in fiscal 2025.
• · The proxy statement is dated August 17, 2026, and the annual meeting date is not specified in the excerpt.
• · No family relationships exist among directors or nominees.

17-08-2026

Twin Vee PowerCats, Co. filed a DEF 14A proxy statement with the SEC on August 17, 2026, soliciting stockholder votes for a special meeting to approve three proposals: ratification of a reverse stock split, a company name change, and an adjournment proposal. The record date was August 10, 2026, with 574,502 shares of common stock issued and outstanding, although 12,813 shares are deemed putative and ineligible to vote on the ratification proposal due to defective corporate acts. The Board recommends voting FOR all proposals.

• · Proxy materials first sent to stockholders on August 17, 2026.
• · Special Meeting will be virtual; internet and telephone proxy voting deadline is 11:59 p.m. Eastern Time on September 7, 2026.
• · The record date for voting is August 10, 2026.
• · A quorum requires at least 1/3 of shares issued, outstanding, and entitled to vote to be present virtually or by proxy.
• · Proposal 1 passes if 'For' votes exceed 'Against' votes; abstentions have no effect.
• · Proposal 2 (Name Change) and Proposal 3 (Adjournment) require affirmative vote from majority of voting power present; abstentions count as votes against.
• · Broker non-votes are expected for Proposal 1 (non-routine) but not for Proposals 2 and 3 (routine).

17-08-2026

Medtronic plc filed its definitive proxy statement (DEF 14A) for the 2026 Annual General Meeting to be held on October 15, 2026, in Galway, Ireland. The meeting agenda includes the election of twelve director nominees, ratification of PricewaterhouseCoopers as independent auditor, an advisory vote on executive compensation, and several Irish law authorities including share issuance and share buyback authorization. The record date for voting is August 21, 2026, and the proxy materials are being made available electronically.

• · The meeting will be held at The Galmont Hotel & Spa, Galway, Ireland at 8:00 a.m. local time.
• · Proposals 1 (director election) and 3 (advisory vote on executive compensation) are non-routine matters under NYSE rules, requiring specific voting instructions from beneficial owners.
• · Proposal 5 (opt out of pre-emption rights) is a special resolution requiring at least 75% of votes cast to pass.
• · The Notice of Internet Availability will be mailed to shareholders on or about September 3, 2026.
• · Shareholders may attend the meeting with proof of ownership and may bring one guest.

17-08-2026

BPGC Acquisition Corp. filed a definitive proxy statement (DEF 14A) seeking shareholder approval to extend the deadline (the 'Extension') for completing a Business Combination, as prior extensions have not resulted in a deal. The company warns that even if approved, redemptions could leave it with insufficient cash to close a transaction, and its securities are not currently listed on any exchange, preventing open-market sales. Additionally, the filing outlines risks of being deemed an investment company under the Investment Company Act, which could force liquidation and cause warrants to expire worthless.

• · The sponsor, Ross Holding Company LLC, is a Cayman Islands entity but is ultimately controlled by U.S. nationals Nadim Z. Qureshi and Stephen J. Toy
• · If deemed an investment company, the company would face burdensome compliance, registration, and restrictions on investments and securities issuance
• · Trust account proceeds were initially invested in U.S. government securities (≤185 days) and Rule 2a-7 money market funds, then liquidated into an interest-bearing demand deposit account at the 24-month anniversary of the IPO
• · Potential CFIUS review could block or condition a Business Combination with a U.S. target, and the limited time window may force liquidation if approvals are delayed
• · No specific dollar amounts, percentages, or period-over-period comparisons were provided in the filing

17-08-2026

Inhibitor Therapeutics, Inc. (INTI) filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders to be held virtually on September 15, 2026. The meeting will cover six proposals: election of six director nominees, ratification of Cherry Bekaert LLP as auditor, approval of the 2025 Share Incentive Plan, an advisory vote on executive compensation (Say-on-Pay), an advisory vote on the frequency of future Say-on-Pay votes, and an adjournment proposal. As of the record date of July 20, 2026, there were 173,791,968 shares of common stock outstanding and entitled to vote.

• · The annual meeting will be held virtually at www.virtualshareholdermeeting.com/HPPI2026 on September 15, 2026 at 10 a.m. Eastern Time.
• · The record date for voting is July 20, 2026.
• · The Board recommends voting 'For' all director nominees, 'For' 3 Years under the Frequency Proposal, and 'For' all other proposals.
• · The proxy materials include the Annual Report on Form 10-K for the year ended December 31, 2025.

17-08-2026

EQ Advisors Trust filed a definitive proxy statement (DEF 14A) for a Special Meeting of Shareholders scheduled for October 27, 2026, to approve new investment advisory and sub-advisory agreements following an anticipated all-stock merger that will change the indirect ownership of the adviser and its affiliates. The new agreements are substantively identical to current ones, with no expected changes to fee rates, portfolio management, or service quality. Contractholders as of June 30, 2026 are entitled to instruct their insurance companies on voting.

• · Special Meeting of Shareholders scheduled for October 27, 2026 at 11:00 a.m. Eastern time at the Trust's offices in New York.
• · Record date for voting is June 30, 2026.
• · The proxy statement covers numerous portfolios, including 1290 VT Equity Income, EQ/International Core Managed Volatility, and many others.
• · The merger is an all-stock transaction and will cause current investment advisory and sub-advisory agreements to terminate.
• · The new agreements are substantively identical except for effective and termination dates.

17-08-2026

1290 Funds filed a definitive proxy statement (DEF 14A) for a Special Meeting of Shareholders scheduled for October 27, 2026. Shareholders of eight funds are asked to approve a new investment advisory agreement with Equitable Investment Management, LLC (EIM) due to an anticipated change of control from an all-stock merger between Equitable Holdings and Corebridge Financial, and to elect 12 trustee nominees (10 current + 2 new). The new advisory agreement is substantively identical to the current one, with no changes to fee rates, portfolio management, or fund strategies.

• · Special Meeting date: October 27, 2026 at 11:30 a.m. Eastern time at 1345 Avenue of the Americas, 3rd Floor, New York, NY 10105.
• · Record date for voting: June 30, 2026.
• · Proxy expenses: 82% borne by Equitable Holdings, Inc., 18% by the Trust; Adviser may bear excess costs under Expense Limitation Agreement.
• · Transaction expected to close on or about January 1, 2027.
• · New trustee nominees (if elected) would begin service in January 2027.